The FDA has revised its guidance on testing a new drug’s genotoxicity to help drugmakers optimize the standard genetic toxicology battery and better predict potential human risks.
Guidance Optimizes Genotoxicity Tests, Aids in Risk Characterization
- Post author:Sam
- Post published:April 7, 2016
- Post category:Washington Drug Letter